FdaApplication
ANDA 212857
Identifiers
- fda_app_no: ANDA212857
Properties
| Property | Value |
|---|---|
| applicant_name | TAGI PHARMA INC |
| application_type | ANDA |
| approval_date | 2020-11-23 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DEXMEDETOMIDINE HYDROCHLORIDE | DEXMEDETOMIDINE HYDROCHLORIDE | EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) | INJECTABLE;INJECTION |
| DEXMEDETOMIDINE HYDROCHLORIDE | DEXMEDETOMIDINE HYDROCHLORIDE | EQ 80MCG BASE/20ML (EQ 4MCG BASE/ML) | INJECTABLE;INJECTION |
| DEXMEDETOMIDINE HYDROCHLORIDE | DEXMEDETOMIDINE HYDROCHLORIDE | EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML) | INJECTABLE;INJECTION |
3 products